Caliber Imaging & Diagnostics, Inc. (LCDX)
- Previous Close
0.0001 - Open
0.0001 - Bid --
- Ask --
- Day's Range
0.0001 - 0.0001 - 52 Week Range
0.0001 - 0.0501 - Volume
10,000 - Avg. Volume
477 - Market Cap (intraday)
3.658M - Beta (5Y Monthly) 0.54
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.
www.caliberid.comRelated News
Performance Overview: LCDX
Trailing total returns as of 4/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LCDX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LCDX
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
2.72
Enterprise Value/EBITDA
-1.59
Financial Highlights
Profitability and Income Statement
Profit Margin
-198.99%
Return on Assets (ttm)
-174.77%
Return on Equity (ttm)
--
Revenue (ttm)
3.14M
Net Income Avi to Common (ttm)
-6.25M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
229.54k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-3.01M
Company Insights: LCDX
LCDX does not have Company Insights